BC
SSKN

Broadfin Capital’s Strata Skin Sciences SSKN Stock Holding History

Broadfin Capital’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$3.83M Sell
183,937
-107,755
-37% -$2.45M 0.51% 34
2019
Q3 		$6.27M Sell
291,692
-33,970
-10% -$796K 1.16% 22
2019
Q2 		$8.11M Buy
325,662
+39,030
+14% +$974K 1.76% 21
2019
Q1 		$8.17M Buy
286,632
+69,496
+32% +$2.11M 1.69% 23
2018
Q4 		$5.65M Sell
217,136
-1,000
-0.5% -$28.6K 0.74% 32
2018
Q3 		$7.72M Sell
218,136
-76,246
-26% -$1.87M 1.14% 27
2018
Q2 		$6.04M Buy
294,382
+274,047
+1,348% +$4.47M 0.95% 31
2018
Q1 		$238K Hold
20,335
– – 0.04% 51
2017
Q4 		$250K Buy
20,335
+15,552
+325% +$217K 0.04% 46
2017
Q3 		$85K Sell
4,783
-1,878
-28% -$34.6K 0.01% 45
2017
Q2 		$162K Sell
6,661
-12,567
-65% -$350K 0.02% 54
2017
Q1 		$582K Hold
19,228
– – 0.07% 54
2016
Q4 		$423K Hold
19,228
– – 0.05% 63
2016
Q3 		$510K Hold
19,228
– – 0.05% 70
2016
Q2 		$586K Sell
19,228
-938
-5% -$37.8K 0.06% 69
2016
Q1 		$953K Sell
20,166
-5,320
-21% -$275K 0.09% 69
2015
Q4 		$1.41M Hold
25,486
– – 0.09% 84
2015
Q3 		$1.45M Buy
25,486
+17,813
+232% +$1.03M 0.08% 87
2015
Q2 		$441K Sell
7,673
-4,085
-35% -$333K 0.02% 93
2015
Q1 		$1.51M Buy
+11,758
New +$1.16M 0.12% 77
2014
Q2 		– Sell
-8
Closed -$2.97M – 78
2014
Q1 		$2.97M Buy
+8
New +$2.81K 0.29% 73

Other funds holding SSKN

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Broadfin Capital's SSKN Position: Q4 2019 in Review

Broadfin Capital reduced its Strata Skin Sciences (SSKN) stake by 37% in Q4 2019, selling an estimated $2.45M and leaving 183,937 shares worth $3.83M. The position accounts for 0.51% of the portfolio, ranked #34.

Broadfin Capital first reported a position in SSKN in Q1 2014 and has held it in 21 quarters since. The position peaked at $8.17M in Q1 2019. 25 funds tracked by Wall St. Rank hold SSKN as of Q4 2019.

  • Broadfin Capital held 183,937 shares of Strata Skin Sciences worth $3.83M as of Q4 2019.
  • Broadfin Capital sold 107,755 Strata Skin Sciences shares in Q4 2019, an estimated $2.45M.
  • Strata Skin Sciences made up 0.51% of Broadfin Capital's portfolio in Q4 2019, its #34 holding.
  • Broadfin Capital first reported a position in Strata Skin Sciences in Q1 2014 and has held it in 21 quarters since.
  • Broadfin Capital's Strata Skin Sciences position peaked at $8.17M in Q1 2019.
  • 25 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q4 2019.

Based on Broadfin Capital's 13F filing for Q4 2019, filed 14 Feb 2020.